CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.

Chiva-Blanch, Gemma; Suades Soler, Rosa, 1984-; Crespo, Javier; Vilahur, Gemma; Arderiu, Gemma; Padró, Teresa; Corella, Dolores; Salas-Salvadó, Jordi; Arós, Fernando; Martínez-González, Miguel A.; Ros, Emilio; Fitó Colomer, Montserrat; Estruch, Ramón; Badimón, Lina, 1953-

Home
→
Recerca: articles, congressos, llibres
→
Hospital del Mar Research Institute
→
Articles (Hospital del Mar Research Institute)
→
View Item

CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event.

Document Type: Article

Version: Accepted version

Date: 2016

Name: chiva-ijc-cd3+.pdf

Size: 546.2Kb

Format: PDF

View/Open

Citation: Chiva-Blanch G, Suades R, Crespo J, Vilahur G, Arderiu G, Padró T. et al. CD3(+)/CD45(+) and SMA-α(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int J Cardiol. 2016 Apr 1;208:147-9. doi: 10.1016/j.ijcard.2016.01.211

Permanent link: http://hdl.handle.net/10230/27086

Abstract:

Circulating microparticles (cMPs) are phospholipid-rich blebs of 0.1–1.0 μm in size shed from the plasma membrane of eukaryotic cells when injured, activated, or undergoing apoptosis. MPs have been shown to reflect cellular activation and/or tissue degeneration occurring in vivo.